{"title":"原发性血小板血症的发展管理。","authors":"Tiziano Barbui","doi":"10.1111/j.1600-0609.2007.00939.x","DOIUrl":null,"url":null,"abstract":"The unified definition of clinical resistance and intolerance to hydroxyurea (HU) (1) is an important development in the management of essential thrombocythaemia (ET). In this article, the evolution of ET treatment will be reviewed in order to demonstrate why the consensus definition is necessary. More detailed discussions of the consensus process used to develop the definition and its implications for clinical practice are provided in the articles that follow.","PeriodicalId":11926,"journal":{"name":"European journal of haematology. Supplementum","volume":" 68","pages":"22-3"},"PeriodicalIF":0.0000,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/j.1600-0609.2007.00939.x","citationCount":"0","resultStr":"{\"title\":\"Evolving management of essential thrombocythaemia.\",\"authors\":\"Tiziano Barbui\",\"doi\":\"10.1111/j.1600-0609.2007.00939.x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The unified definition of clinical resistance and intolerance to hydroxyurea (HU) (1) is an important development in the management of essential thrombocythaemia (ET). In this article, the evolution of ET treatment will be reviewed in order to demonstrate why the consensus definition is necessary. More detailed discussions of the consensus process used to develop the definition and its implications for clinical practice are provided in the articles that follow.\",\"PeriodicalId\":11926,\"journal\":{\"name\":\"European journal of haematology. Supplementum\",\"volume\":\" 68\",\"pages\":\"22-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2007-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1111/j.1600-0609.2007.00939.x\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European journal of haematology. Supplementum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1111/j.1600-0609.2007.00939.x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of haematology. Supplementum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/j.1600-0609.2007.00939.x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evolving management of essential thrombocythaemia.
The unified definition of clinical resistance and intolerance to hydroxyurea (HU) (1) is an important development in the management of essential thrombocythaemia (ET). In this article, the evolution of ET treatment will be reviewed in order to demonstrate why the consensus definition is necessary. More detailed discussions of the consensus process used to develop the definition and its implications for clinical practice are provided in the articles that follow.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
